QuamCore has developed a fully designed and simulated superconducting architecture that it says can scale to 1 million qubits in a single cryostat by embedding ultra‑low‑power superconducting digital control logic directly inside the cryostat. The design reduces cabling by orders of magnitude, removes the primary thermal bottleneck that limits current superconducting systems, and includes built‑in error correction to support fault‑tolerant operation. The company positions its approach as a way to eliminate multi‑cryostat infrastructure and fundamentally change the economics of quantum computing. QuamCore aims to make quantum computing viable for real‑world applications such as drug discovery, advanced materials, AI, and energy by unlocking much higher qubit density. Financially, QuamCore announced a $26M Series A that brings total funding to $35M and received a $4M non‑dilutive grant from the Israel Innovation Authority. The company is based in Tel Aviv, Israel. QuamCore emerged from stealth after two years of development with a patented superconducting quantum processor architecture that it says enables integration of 1 million qubits into a single cryostat. The design aims to dramatically reduce cabling by a factor of more than 1,000, cutting size, energy consumption, and cost compared with current multi‑cryostat approaches. The company highlights built‑in error correction and an architecture‑first approach intended to enable fault‑tolerant, large‑scale quantum systems for applications in pharmaceuticals, AI, materials science, and energy. QuamCore was founded in 2022 and is based in Herzliya, Israel. Its leadership includes CEO Alon Cohen and senior scientific and academic founders and advisors from the Technion, the Weizmann Institute, and the University of Rochester. The company announced $9 million in seed funding as it transitions out of stealth to advance its processor architecture toward practical large‑scale quantum computing.

Total raised

$35M

Funding rounds

3

Latest round

Grant

Latest activity

Aug 2025